```html

Mycobacterium avium Complex (MAC) Infection – A Patient‑Friendly Guide

Overview

Mycobacterium avium complex (MAC) is a group of nontuberculous mycobacteria (NTM) that includes Mycobacterium avium and Mycobacterium intracellulare. These bacteria are found ubiquitously in soil, water, and dust. Unlike tuberculosis, MAC does not spread from person to person; infection occurs when a person inhales or ingests the organisms.

MAC infection can involve the lungs, lymph nodes, gastrointestinal tract, skin, or disseminate throughout the body. It is most common in two populations:

• Older adults with chronic lung disease (e.g., chronic obstructive pulmonary disease — COPD, bronchiectasis, emphysema).
• People with weakened immune systems, especially those with advanced HIV/AIDS (CD4 < 50 cells/µL), hematologic malignancies, organ transplants, or on long‑term immunosuppressive therapy.

According to the U.S. CDC, MAC is the most frequently isolated NTM in the United States, accounting for ~70 % of pulmonary NTM isolates. Prevalence estimates range from 4–9 cases per 100,000 persons, and rates are rising, likely due to increased awareness, aging populations, and improved laboratory detection.

Symptoms

Symptoms vary based on the site of infection. Below is a complete list with brief descriptions.

Pulmonary (Lung) MAC

• Chronic cough – often a dry, “productive” cough that persists for months.
• Fatigue & weakness – a general feeling of being unwell.
• Weight loss – unintended loss of ≥5 % body weight over 6–12 months.
• Shortness of breath – especially during exertion.
• Night sweats – drenching sweats that may soak clothing.
• Hemoptysis – coughing up blood or blood‑streaked sputum (less common).
• Chest pain – often a dull ache that worsens with deep breathing.

Disseminated MAC (usually in advanced HIV/AIDS)

• Fever that may be intermittent.
• Profound weight loss and loss of appetite.
• Diarrhea or vague abdominal discomfort.
• Enlarged lymph nodes (especially cervical).
• Hepatosplenomegaly – enlargement of liver and spleen causing abdominal fullness.
• Skin lesions – papules, nodules, or ulcerations.

Gastrointestinal MAC (rare, mostly in immunocompromised)

• Abdominal pain, cramping.
• Chronic watery or bloody diarrhea.
• Malabsorption leading to nutrient deficiencies.

Skin & Soft‑Tissue MAC

• Slow‑growing nodules, plaques, or ulcers at the site of inoculation (often following trauma).
• Redness, swelling, and occasional drainage.

Causes and Risk Factors

How MAC Causes Infection

MAC bacteria are environmental opportunists. Infection typically follows one of three pathways:

1. Inhalation of aerosolized organisms from contaminated water (e.g., showers, hot tubs, humidifiers) leading to lung disease.
2. Ingestion of contaminated water or food, which can cause gastrointestinal or disseminated disease, especially in immunocompromised hosts.
3. Direct inoculation through skin trauma (e.g., cuts, surgical wounds) resulting in localized skin infection.

Key Risk Factors

• HIV infection with CD4 < 50 cells/µL – accounts for >80 % of disseminated MAC cases worldwide.
• Chronic lung diseases – bronchiectasis, COPD, cystic fibrosis, prior TB.
• Age ≥ 65 years – immune senescence and higher prevalence of lung disease.
• Immunosuppressive medications – corticosteroids, TNF‑α inhibitors, chemotherapy.
• Genetic susceptibility – mutations in CFTR, ciliary genes, or immune pathways (e.g., IFN‑γ pathway).
• Environmental exposure – frequent hot‑tub use, aerosolized water devices, exposure to dust/soil.
• Malnutrition – low body weight and vitamin deficiencies diminish cellular immunity.

Diagnosis

Diagnosing MAC infection requires a combination of clinical, radiographic, and microbiologic data. No single test is definitive.

Clinical Evaluation

• Detailed history (exposures, immune status, underlying lung disease).
• Physical exam focused on lungs, abdomen, lymph nodes, and skin.

Radiographic Imaging

• Chest X‑ray – may show nodular infiltrates, bronchiectasis, or cavitary lesions.
• High‑resolution CT (HRCT) – the gold standard for pulmonary MAC; looks for “tree‑in‑bud” opacities, bronchiectasis, and nodules.

Microbiologic Tests

1. Sputum cultures – at least three separate early‑morning sputum specimens; growth of MAC on acid‑fast bacilli (AFB) media confirms presence.
2. Bronchoscopy with bronchoalveolar lavage (BAL) – used when sputum is negative but suspicion remains.
3. Blood cultures – essential for suspected disseminated disease, especially in HIV patients.
4. Biopsy – lung or lymph node tissue showing granulomatous inflammation with AFB stains positive for MAC.

Laboratory Markers

• Complete blood count (CBC) – anemia of chronic disease may be present.
• Serum albumin – low levels indicate malnutrition, a poor prognostic sign.
• HIV viral load and CD4 count – guide treatment intensity in HIV‑positive patients.

Diagnostic Criteria (American Thoracic Society/Infectious Diseases Society of America)

For pulmonary MAC, a diagnosis is made when **all three** of the following are met:

1. Compatible pulmonary symptoms.
2. Radiographic abnormalities (nodules, cavities, bronchiectasis).
3. Microbiologic evidence – either ≥2 positive sputum cultures, or ≥1 positive BAL, or lung tissue with histopathology plus culture.

Treatment Options

General Principles

• MAC treatment is prolonged (typically 12‑18 months) and must be personalized.
• Therapy combines multiple antibiotics to prevent resistance.
• Regular monitoring for drug toxicity and treatment response is essential.

First‑Line Antibiotic Regimens

Drug	Typical Dose (adult)	Key Side Effects
Azithromycin 500 mg daily (or 250 mg three times weekly)	GI upset, QT prolongation
Clarithromycin 500 mg twice daily	Taste disturbance, hepatotoxicity, drug interactions
Ethambutol 15 mg/kg daily	Optic neuritis (monitor vision), rash
Rifampin 600 mg daily	Hepatitis, orange body fluids, many drug interactions

**Standard regimen** for pulmonary MAC: • Azithromycin (or clarithromycin) + Ethambutol + Rifampin for ≥12 months after culture conversion.
For disseminated MAC in HIV patients: • Azithromycin + Ethambutol ± Rifabutin (instead of rifampin to avoid severe drug interactions with antiretrovirals).

Adjunctive Therapies

• Corticosteroids – occasionally used in severe airway inflammation, but only under specialist supervision.
• Antiretroviral therapy (ART) – for HIV patients, initiating ART improves immune function and reduces MAC recurrence.
• Surgical resection – considered for localized disease refractory to antibiotics or causing massive hemoptysis.

Monitoring During Treatment

• Sputum cultures every 2‑3 months until three consecutive negatives.
• Liver function tests (ALT, AST, bilirubin) monthly for the first 3 months, then quarterly.
• Visual acuity and color vision testing every 2 months when on ethambutol.
• Electrolytes and complete blood count to detect marrow suppression.

Lifestyle & Supportive Measures

• Nutrition: high‑protein diet, vitamin D supplementation (if deficient).
• Smoking cessation – essential for pulmonary patients.
• Hydration & humidifier hygiene – use distilled water, clean weekly to reduce aerosolized MAC.
• Physical activity as tolerated to maintain lung capacity.

Living with Mycobacterium avium Complex (MAC) Infection

Daily Management Tips

• Medication adherence – use a pill organizer, set alarms, and keep a medication diary.
• Track symptoms – note cough frequency, weight changes, fevers, and side effects; share with your clinician.
• Protect your lungs – avoid dust, molds, and secondhand smoke; wear a mask when cleaning or gardening.
• Maintain water hygiene – install point‑of‑use filters (0.2 µm) on showers and faucets; empty hot‑tub water daily.
• Vaccinations – stay up‑to‑date on influenza, pneumococcal (PCV20 or PCV15 + PPSV23), and COVID‑19 vaccines.
• Regular follow‑up – keep appointments with your pulmonologist or infectious disease specialist, even when feeling well.

Emotional & Social Support

Chronic infection can be stressful. Consider:

• Joining NTM patient support groups (online forums, local meet‑ups).
• Speaking with a mental‑health professional if anxiety or depression arises.
• Engaging family or caregivers in medication management.

Prevention

• Water safety – filter or boil water before drinking; avoid drinking from untreated sources.
• Environmental control – clean showerheads and faucets monthly with a 5 % bleach solution.
• Limit exposure to aerosol generators – use sterile water in CPAP machines, avoid sharing humidifiers.
• Smoking cessation – the single most effective way to reduce lung MAC risk.
• Immune optimization – manage diabetes, maintain a healthy weight, and treat HIV promptly.
• Prophylactic antibiotics – in HIV patients with CD4 < 50 cells/µL, daily azithromycin 1200 mg once weekly is recommended by the CDC.

Complications

If MAC infection is left untreated or treatment is inadequate, several serious complications can develop:

• Progressive lung destruction – bronchiectasis, cavitation, and respiratory failure.
• Pneumothorax – collapsed lung from ruptured cavities.
• Disseminated disease – especially in HIV, leading to multi‑organ failure.
• Septicemia – rare but possible with bloodstream invasion.
• Drug‑induced toxicities – liver failure, optic neuritis, or severe electrolyte disturbances that may require hospitalization.
• Secondary infections – MAC can coexist with bacterial pneumonia or fungal infections, complicating management.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institute of Allergy and Infectious Diseases (NIAID), American Thoracic Society/IDSA Guidelines (2020), WHO NTM Fact Sheet, Cleveland Clinic. All information is for educational purposes and does not replace professional medical advice.

```